Amedisys (Nasdaq: AMED) exceeded Wall Street expectations in its first-quarter results for 2025. The company’s home health segment benefited from ...

In a report released today, Matt Larew from William Blair maintained a Hold rating on Amedisys (AMED – Research Report). The company’s shares ...

Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025. Three-Month Periods Ended March ...

Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity Care. Although the revenue and EPS for Amedisys (AMED) give a sense of how ...

Amedisys delivers first-quarter top-line growth across three of its segments, namely Home Health, Hospice and High Acuity ...

(2) Adjusted EBITDA is defined as net income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain items as ...

U.S. crude oil inventories rose for a fourth consecutive week amid higher net imports, while refineries ramped up their capacity use. Commercial crude oil stocks excluding the Strategic Petroleum ...

Although home-based care providers and industry experts initially entered 2025 with a renewed level of optimism regarding ...

UnitedHealth faced a sharp decline following the release of its quarterly results, dropping 22.38% on April 17 and another ...

A federal class action lawsuit filed in Texas accuses Toyota and a telematics affiliate of unlawfully collecting and selling drivers' vehicle data to Progressive Insurance. The suit claims Toyota ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

A tradition dating back to the 1930s will again wind its way through the streets of Uniontown. The 92nd annual Americanism ...